Arturo García-Touchard, Manel Sabaté, Nieves Gonzalo, Vicente Peral, Beatriz Vaquerizo, Rafael Ruiz-Salmerón, Bruno García Del Blanco, Jesús Jiménez-Mazuecos, Eduardo Molina, Pedro Martínez-Romero, José María Hernandez-García, Valeriano Ruiz-Quevedo, Cristóbal Urbano, Javier Fernández-Portales, José Ramón Rumoroso, Juan Casanova-Sandoval, Eduardo Pinar, Javier Lopez-Pais, Juan Francisco Oteo, Fernando Alfonso
BACKGROUND: Drug-eluting stents (DES) are considered the therapy of choice in ST-segment elevation myocardial infarction (STEMI); however, a low persistent rate of revascularizations and stent thrombosis exist over the time. We have previously shown that a paclitaxel (PTX)-drug-coated balloon (DCB) after a bare-metal stent (BMS) implantation (DCB-combined strategy) yields superior angiographic and clinical results compared to BMS in the short term. However, the long-term safety and efficacy of this approach remain uncertain...
October 31, 2023: Cardiovascular Diagnosis and Therapy